LeMaitre Vascular Inc (LMAT)
Return on total capital
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 57,080 | 39,475 | 27,490 | 36,506 | 28,666 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 337,290 | 297,900 | 268,201 | 254,151 | 172,572 |
| Return on total capital | 16.92% | 13.25% | 10.25% | 14.36% | 16.61% |
December 31, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $57,080K ÷ ($—K + $337,290K)
= 16.92%
The return on total capital for LeMaitre Vascular Inc showed a declining trend over the years from 2020 to 2022, decreasing from 16.61% in 2020 to 10.25% in 2022. However, there was a rebound in 2023 and 2024, with the return on total capital increasing to 13.25% and 16.92%, respectively. This indicates that the company's ability to generate profit from its total capital fluctuated during the period under review. Further analysis would be needed to understand the factors contributing to these fluctuations and assess the company's overall financial performance and efficiency in utilizing its capital.
Peer comparison
Dec 31, 2024